National advisory committee recommends AstraZeneca vaccine for people 30 and older

National advisory committee recommends AstraZeneca vaccine for people 30 and older

An Ontario man in his 60s developed blood clotting after receiving a first dose of the AstraZeneca vaccine, Chief Medical Officer of Health Dr. David Williams reported Friday.

Ontario has confirmed its first case of a rare blood clot in a 60-year-old male patient after the individual received the AstraZeneca/COVISHIELD COVID-19 vaccine. No other details will be released to protect the man's privacy.

"The health and safety of Ontarians remains our top priority", Williams said in a statement.

"At this time, and based on current evidence, NACI recommends that the AstraZeneca COVID-19 vaccine may be offered to individuals 30 years of age and older, without contraindications, if the individual does not wish to wait for an mRNA vaccine, and the benefits outweigh the risks", said Dr. Shelley Deeks, NACI vice-chair.

Just yesterday, Prime Minister Justin Trudeau announced he will be getting the AstraZenca vaccine.

Ontario will also continue to offer the AstraZeneca vaccine to individuals aged 40 years and over at the time of vaccination or any time in 2021.

The federal government has said that 4.1 million more doses of the vaccine are expected to arrive in the country by the end of June, but a delivery schedule to the provinces has not yet been published.

Health Canada has approved the vaccine and has said the benefits outweigh the risks.

"I would expect the true number of cases per million doses of vaccine to become clear fairly soon as these reports stabilise, but it is already clear that it is going to remain a very rare event", University of Bristol paediatrics professor Adam Finn said.

Moderna and the Defense Health Agency conducted a review and determined the doses nevertheless pose no risk to those at Fort Meade who received them.

Related Articles